本页面由Tiger Trade Technology Pte. Ltd.提供服务

Forte BioSciences Inc

29.66
+5.7824.20%
盘前29.59-0.0700-0.24%04:39 EST
成交量:42.34万
成交额:1,228.89万
市值:3.72亿
市盈率:-6.75
高:30.50
开:23.63
低:23.63
收:23.88
52周最高:31.27
52周最低:4.90
股本:1,252.69万
流通股本:926.19万
量比:2.44
换手率:4.57%
股息:- -
股息率:- -
每股收益(TTM):-4.3909
每股收益(LYR):-12.1671
净资产收益率:-110.72%
总资产收益率:-58.07%
市净率:4.42
市盈率(LYR):-2.44

数据加载中...

2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/15

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/20

重要事件披露

Form 8-K - Current report
2024/08/30

重要事件披露

Form 8-K - Current report
2024/08/22

重要事件披露

Form 8-K - Current report
2024/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/14

重要事件披露

Form 8-K - Current report
2024/06/17

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/13

重要事件披露

Form 8-K - Current report
2024/04/29

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/04/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/18

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/18

重要事件披露

Form 8-K - Current report
2024/02/16

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/15

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals